NCT06522347 Mycobacteria Registry Study: Prospective Observational Study in Austria
| NCT ID | NCT06522347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig Boltzmann Institute for Lung Health |
| Condition | Non-Tuberculous Mycobacterial Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2053-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-01-01 with a primary completion date of 2053-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is: What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria? Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
Eligibility Criteria
Inclusion Criteria: * patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection * individuals aged 18 years or older * written informed consent Exclusion Criteria: * to not comprehend and rightfully judge participation
Frequently Asked Questions
Who can join the NCT06522347 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-Tuberculous Mycobacterial Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06522347 currently recruiting?
Yes, NCT06522347 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ludwig Boltzmann Institute for Lung Health to inquire about joining.
Where is the NCT06522347 trial being conducted?
This trial is being conducted at Vienna, Austria, Vienna, Austria, Vienna, Austria.
Who is sponsoring the NCT06522347 clinical trial?
NCT06522347 is sponsored by Ludwig Boltzmann Institute for Lung Health. The trial plans to enroll 1,000 participants.